These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8985194)

  • 1. Antibody and antibody-dependent cellular cytotoxicity responses against the BamHI A rightward open-reading frame-1 protein of Epstein-Barr virus (EBV) in EBV-associated disorders.
    Tanner JE; Wei MX; Alfieri C; Ahmad A; Taylor P; Ooka T; Menezes J
    J Infect Dis; 1997 Jan; 175(1):38-46. PubMed ID: 8985194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-interleukin-10 antibodies in patients with chronic active Epstein-Barr virus infection.
    Tanner JE; Diaz-Mitoma F; Rooney CM; Alfieri C
    J Infect Dis; 1997 Dec; 176(6):1454-61. PubMed ID: 9395354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus gp350-specific antibody titers and antibody-dependent cellular cytotoxic effector function in different groups of patients: a study using cloned gp350-expressing transfected human T cell targets.
    Khyatti M; Stefanescu I; Blagdon M; Menezes J
    J Infect Dis; 1994 Dec; 170(6):1439-47. PubMed ID: 7995983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purified hexameric Epstein-Barr virus-encoded BARF1 protein for measuring anti-BARF1 antibody responses in nasopharyngeal carcinoma patients.
    Hoebe EK; Hutajulu SH; van Beek J; Stevens SJ; Paramita DK; Greijer AE; Middeldorp JM
    Clin Vaccine Immunol; 2011 Feb; 18(2):298-304. PubMed ID: 21123521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The disease associations of the antibody response against the Epstein-Barr virus transactivator protein ZEBRA can be separated into different epitopes.
    Tedeschi R; Foong YT; Cheng HM; dePaoli P; Lehtinen T; Elfborg T; Dillner J
    J Gen Virol; 1995 Jun; 76 ( Pt 6)():1393-400. PubMed ID: 7540196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unique variations of Epstein-Barr virus-encoded BARF1 gene in nasopharyngeal carcinoma biopsies.
    Wang Y; Wang XF; Sun ZF; Luo B
    Virus Res; 2012 Jun; 166(1-2):23-30. PubMed ID: 22406129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Epstein-Barr virus (EBV) major envelope glycoprotein gp350/220-specific antibody reactivities in the sera of patients with different EBV-associated diseases.
    Xu J; Ahmad A; Blagdon M; D'Addario M; Jones JF; Dolcetti R; Vaccher E; Prasad U; Menezes J
    Int J Cancer; 1998 Oct; 79(5):481-6. PubMed ID: 9761116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody against the Epstein-Barr virus BHRF1 protein, a homologue of Bcl-2, in patients with nasopharyngeal carcinoma.
    Liu MY; Shih YY; Chou SP; Chen CJ; Sheen TS; Yang CS; Chen JY
    J Med Virol; 1998 Nov; 56(3):179-85. PubMed ID: 9783682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune response to different sequences of the EBNA I molecule in Epstein-Barr virus-related disorders and in autoimmune diseases.
    Marchini B; Dolcher MP; Sabbatini A; Klein G; Migliorini P
    J Autoimmun; 1994 Apr; 7(2):179-91. PubMed ID: 7518683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of antibodies to the Epstein-Barr virus immediate early gene product ZEBRA by a new enzyme-linked immunosorbent assay.
    Yamauchi Y; Tachiband Y; Maeda A; Wakiguchi H; Usui M; Kurata T; Sairenji T
    Intervirology; 1998; 41(6):278-84. PubMed ID: 10325538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning and expression of the Epstein-Barr virus-encoded dUTPase: patients with acute, reactivated or chronic virus infection develop antibodies against the enzyme.
    Sommer P; Kremmer E; Bier S; König S; Zalud P; Zeppezauer M; Jones JF; Mueller-Lantzsch N; Grässer FA
    J Gen Virol; 1996 Nov; 77 ( Pt 11)():2795-805. PubMed ID: 8922474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus (EBV)-encoded BARF1 gene is expressed in nasopharyngeal carcinoma and EBV-associated gastric carcinoma tissues in the absence of lytic gene expression.
    Seto E; Yang L; Middeldorp J; Sheen TS; Chen JY; Fukayama M; Eizuru Y; Ooka T; Takada K
    J Med Virol; 2005 May; 76(1):82-8. PubMed ID: 15778977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined membrane antigens. I. Reactivity in sera from normal persons and from patients with acute infectious mononucleosis.
    Jondal M
    Clin Exp Immunol; 1976 Jul; 25(1):1-5. PubMed ID: 186222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis and significance of anti-latent membrane protein-1 antibodies in the sera of patients with EBV-associated diseases.
    Xu J; Ahmad A; D'Addario M; Knafo L; Jones JF; Prasad U; Dolcetti R; Vaccher E; Menezes J
    J Immunol; 2000 Mar; 164(5):2815-22. PubMed ID: 10679125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous T cell responses to Epstein-Barr virus-encoded BARF1 protein and derived peptides in patients with nasopharyngeal carcinoma: bases for improved immunotherapy.
    Martorelli D; Houali K; Caggiari L; Vaccher E; Barzan L; Franchin G; Gloghini A; Pavan A; Da Ponte A; Tedeschi RM; De Re V; Carbone A; Ooka T; De Paoli P; Dolcetti R
    Int J Cancer; 2008 Sep; 123(5):1100-7. PubMed ID: 18546263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restricted low-level human antibody responses against Epstein-Barr virus (EBV)-encoded latent membrane protein 1 in a subgroup of patients with EBV-associated diseases.
    Meij P; Vervoort MB; Aarbiou J; van Dissel P; Brink A; Bloemena E; Meijer CJ; Middeldorp JM
    J Infect Dis; 1999 May; 179(5):1108-15. PubMed ID: 10191211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unique transcription pattern of Epstein-Barr virus (EBV) in EBV-carrying gastric adenocarcinomas: expression of the transforming BARF1 gene.
    zur Hausen A; Brink AA; Craanen ME; Middeldorp JM; Meijer CJ; van den Brule AJ
    Cancer Res; 2000 May; 60(10):2745-8. PubMed ID: 10825150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to LMP2A/2B in EBV-carrying malignancies.
    Lennette ET; Winberg G; Yadav M; Enblad G; Klein G
    Eur J Cancer; 1995 Oct; 31A(11):1875-8. PubMed ID: 8541116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The reading frame BPLF1 of Epstein-Barr virus: a homologue of herpes simplex virus protein VP16.
    Schmaus S; Wolf H; Schwarzmann F
    Virus Genes; 2004 Oct; 29(2):267-77. PubMed ID: 15284487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to lytic infection proteins in lymphocryptovirus-infected rhesus macaques: a model for humoral immune responses to epstein-barr virus infection.
    Orlova N; Fogg MH; Carville A; Wang F
    Clin Vaccine Immunol; 2011 Sep; 18(9):1427-34. PubMed ID: 21734064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.